Oragenics is dedicated to becoming a global leader in probiotics for oral health in humans and pets and in novel antibiotics against infectious disease. The company is engaged in developing, marketing and selling proprietary probiotics under the brand names Evora and ProBiora, designed specifically for enhancing oral health for humans and pets. Oragenics has also established an exclusive worldwide channel collaboration for lantibiotics with Intrexon Corporation. For more information, visit the company’s Web site at www.oragenics.com.

The 6th Annual OneMedForum is a gathering of leading investors and management of some of the most promising emerging life science companies in Asia and North America. Through panels, workshops and up-close programming with top industry leaders, attendees explore strategies for company growth finance with healthcare investors looking for outsized returns. For more information, please visit www.onemedforum.com.

Let us hear your thoughts below: